Evidence map›Paper›PMID 23471474›Full record

ReviewCold Spring Harbor perspectives in medicine2013

Erythroid heme biosynthesis and its disorders.

Harry A Dailey, Peter N Meissner

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A reversible feedback mechanism regulating mitochondrial heme synthesis.bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Article
  11. Mechanisms of heme transport in the mitochondria.Biochemical Society transactions · 2025
    Review
  12. Article
  13. CRISPR/Cas9-MediatedInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Harry A DaileyDepartment of Microbiology, Department of Biochemistry and Molecular Biology, Biomedical and Health Sciences Institute, University of Georgia, Athens, GA 30602, USA. hdailey@uga.edu
Peter N Meissner
University of Cape Town · ZAUniversity of Georgia · US

Funding

TERMINAL HEME SYNTHETIC ENZYMESR01DK032303 · NIDDK · UNIVERSITY OF GEORGIA (UGA) · PI DAILEY, HARRY A · 1986 to 2010
$2.4M
Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] clusterR01DK096051 · NIDDK · UNIVERSITY OF GEORGIA · PI DAILEY, HARRY A · 2012 to 2015
$1.5M
Terminal steps in Heme BiosynthesisR56DK032303 · NIDDK · UNIVERSITY OF GEORGIA · PI DAILEY, HARRY A · 2010 to 2010
$175k
NIDDK NIH HHS DK32303NIDDK NIH HHS R01 DK032303NIDDK NIH HHS R01 DK096051NIDDK NIH HHS R56 DK032303
6 · The paper itself

Abstract

Heme, which is composed of iron and the small organic molecule protoporphyrin, is an essential component of hemoglobin as well as a variety of physiologically important hemoproteins. During erythropoiesis, heme synthesis is induced before, and is essential for, globin synthesis. Although all cells possess the ability to synthesize heme, there are distinct differences between regulation of the pathway in developing erythroid cells and all other types of cells. Disorders that compromise the ability of the developing red cell to synthesize heme can have profound medical implications. The biosynthetic pathway for heme and key regulatory features are reviewed herein, along with specific human genetic disorders that arise from defective heme synthesis such as X-linked sideroblastic anemia and erythropoietic protoporphyria.

Indexed as

CoproporphyrinogensEnzymesErythropoiesisHematologic DiseasesHemeHumansMitochondriaCoproporphyrinogensEnzymesHeme

Identifiers

PMID23471474
PMCPMC3683999
OpenAlexW2121864246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.